Summary

The Germany Diagnostic Imaging Market is expected to register a CAGR of 5.2% during the forecast period.

COVID-19 has brought several adverse impacts on imaging services. Hospitals, clinics, and diagnostic centers are unable to provide services due to lockdown situations and social distancing protocols in Germany. Moreover, the tremendous pressure on the hospitals for providing services to COVID-19 patients is also a factor that is leading to declining diagnostic imaging procedures in Germany. However, this impact is expected to last short-term and diagnostics imaging procedures are anticipated to resume soon.

The major factors augmenting the growth of the Germany diagnostic imaging market include an increase in the burden of chronic diseases coupled with increased adoption of advanced technologies in medical imaging and the rise in the geriatric population.

According to the estimates of Globocan 2020, there were approximately 62, 8519new cases of cancer. whereas five-year prevalence of Cancer was found to be 21,88,176 in Germany. The most common cancers in Germany are breast cancer, lung cancer, prostate and colon cancer and bladder.

In addition, as per the article published by NCBI in 2019, “Prevalence of osteoarthritis”, in Germany, was about every third person suffered from chronic joint pain from the age of 20 years, and every second person suffered from the same, from the age of 40. One of the major causes of this pain is rheumatoid arthritis (RA).

These statistics indicate that Germany is having a high burden of chronic diseases is having a larger contribution to the mortality rate of the German population. Therefore, there is a rising need to deal with these diseases by preventing them. Hence, the market for diagnostic imaging is largely driven by the growing chronic diseases and the mortality associated with the same.

Moreover, the direct presence of key market players, such as the German-based Agfa, who is actively participating in advancing the product technologies to address the challenges in digital X-ray imaging techniques, is projected to boost the market growth in the country.

In 2020, Agfa announced the launch of its SmartXR portfolio, a unique combination of hardware and AI-powered software to lighten radiographers’ workload and provide image acquisition support. This Agfa’s imaging devices portfolio offers key assistance during the radiology routine, which has proven to be very important during the COVID-19 crisis. Thus, owing to the presence of a large patient pool and the market development strategies by the players is expected to boost the market growth. However, side effects of radiation is expected to hinder the market growth.

Key Market Trends

Computed Tomography is Expected to Hold Significant Market Share

The computed tomography (CT) market segment is anticipated to hold a significant market share. Factors such as the strong base of global companies working on the development of products, and the increasing prevalence of chronic diseases, and the rising geriatric population in the country, which is more prone to several chronic disorders that require diagnosis by CT is expected to drive the market growth.

As per the German Federal Statistical Office’s 2020 report, there are about 83 million people in Germany. Of these, 16.2 million people are above 67 years of age, and this number is projected to reach 21.4 million by 2040. As the geriatric population increases, the burden of cardiovascular diseases and other chronic disorders also rises, which fuels the market studied.

In April 2020, the European Society of Medical Imaging Informatics initiated a European campaign in Germany and res of European countries to develop a deep learning-based model for the automated detection of abnormalities on chest CT and for quantifying lung involvement.

Furthermore, in November 2019, Siemens Healthineers launched its new Somatom X.cite single-source CT scanner, together with the totally new myExam Companion user guiding system, based on artificial intelligence (AI), in Germany. Thus, this advancement in product technologies to address the challenges in CT imaging techniques is projected to boost the market growth in the country.

Competitive Landscape

The market studied is consolidated in Germany owing to the presence of a few major players in the market. The market players are focusing on R&D to develop the technologically advanced products in order to reduce the cost and side effects associated with the products. The barriers for the new entrants are high in this industry, and hence few major market players hold the maximum market share.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

ページTOPに戻る

Table of Contents

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Burden of Chronic Diseases
4.2.2 Increased Adoption of Advanced Technologies in Medical Imaging
4.3 Market Restraints
4.3.1 Side Effects of Diagnostic Imaging
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Modality
5.1.1 MRI
5.1.2 Computed Tomography
5.1.3 Ultrasound
5.1.4 X-Ray
5.1.5 Other Modalities
5.2 By Application
5.2.1 Cardiology
5.2.2 Oncology
5.2.3 Neurology
5.2.4 Orthopedics
5.2.5 Other Applications
5.3 By End-User
5.3.1 Hospital
5.3.2 Diagnostic Centers
5.3.3 Others

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Agfa-Gevaert Group
6.1.2 Canon Medical Systems
6.1.3 Esaote SpA
6.1.4 Fujifilm Holdings
6.1.5 General Electric (GE Healthcare)
6.1.6 Hitachi Medical Corporation
6.1.7 Hologic Corporation
6.1.8 Koning Corporation
6.1.9 Koninklijke Philips N.V.
6.1.10 Shimadzu Corporation
6.1.11 Siemens Healthineers AG

7 MARKET OPPORTUNITIES AND FUTURE TRENDS